Advertisement admin, Author at Pharmaceutical Business review - Page 325 of 458
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

All articles by Lavillcok Lavillcok

Endo completes acquisition of DAVA Pharmaceuticals

The DAVA portfolio is well-positioned for continued strong financial performance with its existing commercial products and attractive near-term pipeline, and is a natural fit with Endo’s U.S. generics